Most cited causes of TMA in KTR are calcineurin inhibitors (CNI) toxicity [5–8], atypical or typical HUS and mammalian target of rapamycin (mTOR) inhibitors’ toxicity [9]. The gene discussed is MTOR; the disease is hemolytic-uremic syndrome.